Clinical Trials Browser

Not yet recruiting × Triple Negative Breast Neoplasms × Interleukin-2 × Clear all

NCT05821686 2025-02-12

Efficacy of Interleukin-2 in Triple Negative Breast Cancer

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms